nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfentanil—ALB—chronic obstructive pulmonary disease	0.471	1	CbGaD
Alfentanil—ALB—Prednisone—chronic obstructive pulmonary disease	0.0562	0.179	CbGbCtD
Alfentanil—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0554	0.177	CbGbCtD
Alfentanil—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0374	0.119	CbGbCtD
Alfentanil—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0357	0.114	CbGbCtD
Alfentanil—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0318	0.101	CbGbCtD
Alfentanil—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0311	0.0994	CbGbCtD
Alfentanil—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0294	0.0939	CbGbCtD
Alfentanil—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0187	0.0596	CbGbCtD
Alfentanil—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0176	0.0562	CbGbCtD
Alfentanil—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.00117	0.00613	CcSEcCtD
Alfentanil—Epistaxis—Tiotropium—chronic obstructive pulmonary disease	0.00112	0.00587	CcSEcCtD
Alfentanil—Bronchospasm—Arformoterol—chronic obstructive pulmonary disease	0.00106	0.00554	CcSEcCtD
Alfentanil—Bronchospasm—Formoterol—chronic obstructive pulmonary disease	0.00106	0.00554	CcSEcCtD
Alfentanil—Connective tissue disorder—Tiotropium—chronic obstructive pulmonary disease	0.00105	0.00549	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00104	0.00545	CcSEcCtD
Alfentanil—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00104	0.00544	CcSEcCtD
Alfentanil—Visual impairment—Tiotropium—chronic obstructive pulmonary disease	0.00103	0.00538	CcSEcCtD
Alfentanil—Arrhythmia—Aminophylline—chronic obstructive pulmonary disease	0.00101	0.00529	CcSEcCtD
Alfentanil—Bronchospasm—Salbutamol—chronic obstructive pulmonary disease	0.000998	0.00523	CcSEcCtD
Alfentanil—Eye disorder—Tiotropium—chronic obstructive pulmonary disease	0.000996	0.00522	CcSEcCtD
Alfentanil—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.000992	0.0052	CcSEcCtD
Alfentanil—Angiopathy—Tiotropium—chronic obstructive pulmonary disease	0.000967	0.00507	CcSEcCtD
Alfentanil—Immune system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000963	0.00505	CcSEcCtD
Alfentanil—Mediastinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00096	0.00503	CcSEcCtD
Alfentanil—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000956	0.00501	CcSEcCtD
Alfentanil—Arrhythmia—Tiotropium—chronic obstructive pulmonary disease	0.000952	0.00499	CcSEcCtD
Alfentanil—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.000938	0.00492	CcSEcCtD
Alfentanil—Mental disorder—Tiotropium—chronic obstructive pulmonary disease	0.000934	0.00489	CcSEcCtD
Alfentanil—Hiccups—Prednisolone—chronic obstructive pulmonary disease	0.000927	0.00486	CcSEcCtD
Alfentanil—Dermatitis atopic—Prednisone—chronic obstructive pulmonary disease	0.000911	0.00477	CcSEcCtD
Alfentanil—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.000905	0.00474	CcSEcCtD
Alfentanil—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.000904	0.00474	CcSEcCtD
Alfentanil—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000887	0.00465	CcSEcCtD
Alfentanil—Epistaxis—Montelukast—chronic obstructive pulmonary disease	0.000885	0.00464	CcSEcCtD
Alfentanil—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.000874	0.00458	CcSEcCtD
Alfentanil—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000864	0.00453	CcSEcCtD
Alfentanil—Epistaxis—Salbutamol—chronic obstructive pulmonary disease	0.000853	0.00447	CcSEcCtD
Alfentanil—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.000852	0.00447	CcSEcCtD
Alfentanil—Connective tissue disorder—Formoterol—chronic obstructive pulmonary disease	0.000845	0.00443	CcSEcCtD
Alfentanil—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.000845	0.00443	CcSEcCtD
Alfentanil—Visual impairment—Arformoterol—chronic obstructive pulmonary disease	0.000829	0.00434	CcSEcCtD
Alfentanil—Visual impairment—Formoterol—chronic obstructive pulmonary disease	0.000829	0.00434	CcSEcCtD
Alfentanil—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.000828	0.00434	CcSEcCtD
Alfentanil—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.000815	0.00427	CcSEcCtD
Alfentanil—Cough—Tiotropium—chronic obstructive pulmonary disease	0.000809	0.00424	CcSEcCtD
Alfentanil—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000803	0.00421	CcSEcCtD
Alfentanil—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.000801	0.0042	CcSEcCtD
Alfentanil—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.000798	0.00418	CcSEcCtD
Alfentanil—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.000798	0.00418	CcSEcCtD
Alfentanil—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.000798	0.00418	CcSEcCtD
Alfentanil—Euphoric mood—Prednisolone—chronic obstructive pulmonary disease	0.000797	0.00418	CcSEcCtD
Alfentanil—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000796	0.00417	CcSEcCtD
Alfentanil—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000787	0.00413	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.000784	0.00411	CcSEcCtD
Alfentanil—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000784	0.00411	CcSEcCtD
Alfentanil—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.000782	0.0041	CcSEcCtD
Alfentanil—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.000777	0.00407	CcSEcCtD
Alfentanil—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000777	0.00407	CcSEcCtD
Alfentanil—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000775	0.00406	CcSEcCtD
Alfentanil—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000775	0.00406	CcSEcCtD
Alfentanil—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.000768	0.00403	CcSEcCtD
Alfentanil—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.000768	0.00403	CcSEcCtD
Alfentanil—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000765	0.00401	CcSEcCtD
Alfentanil—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.000761	0.00399	CcSEcCtD
Alfentanil—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000759	0.00398	CcSEcCtD
Alfentanil—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000759	0.00398	CcSEcCtD
Alfentanil—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000758	0.00398	CcSEcCtD
Alfentanil—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000754	0.00395	CcSEcCtD
Alfentanil—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.000754	0.00395	CcSEcCtD
Alfentanil—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.000753	0.00395	CcSEcCtD
Alfentanil—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.000753	0.00395	CcSEcCtD
Alfentanil—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00075	0.00393	CcSEcCtD
Alfentanil—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000742	0.00389	CcSEcCtD
Alfentanil—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000739	0.00387	CcSEcCtD
Alfentanil—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.000738	0.00387	CcSEcCtD
Alfentanil—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.000737	0.00386	CcSEcCtD
Alfentanil—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000735	0.00385	CcSEcCtD
Alfentanil—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000733	0.00384	CcSEcCtD
Alfentanil—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000732	0.00384	CcSEcCtD
Alfentanil—Chills—Salbutamol—chronic obstructive pulmonary disease	0.000729	0.00382	CcSEcCtD
Alfentanil—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.000725	0.0038	CcSEcCtD
Alfentanil—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000715	0.00375	CcSEcCtD
Alfentanil—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000711	0.00373	CcSEcCtD
Alfentanil—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.00071	0.00372	CcSEcCtD
Alfentanil—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.000696	0.00365	CcSEcCtD
Alfentanil—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000688	0.00361	CcSEcCtD
Alfentanil—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000688	0.00361	CcSEcCtD
Alfentanil—Hiccups—Prednisone—chronic obstructive pulmonary disease	0.000674	0.00353	CcSEcCtD
Alfentanil—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000674	0.00353	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000654	0.00343	CcSEcCtD
Alfentanil—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000653	0.00342	CcSEcCtD
Alfentanil—Cough—Formoterol—chronic obstructive pulmonary disease	0.000653	0.00342	CcSEcCtD
Alfentanil—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00065	0.00341	CcSEcCtD
Alfentanil—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000646	0.00339	CcSEcCtD
Alfentanil—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000646	0.00339	CcSEcCtD
Alfentanil—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.00064	0.00336	CcSEcCtD
Alfentanil—Cough—Montelukast—chronic obstructive pulmonary disease	0.00064	0.00335	CcSEcCtD
Alfentanil—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000638	0.00334	CcSEcCtD
Alfentanil—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000635	0.00333	CcSEcCtD
Alfentanil—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000635	0.00333	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000633	0.00332	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000633	0.00332	CcSEcCtD
Alfentanil—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000621	0.00326	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00062	0.00325	CcSEcCtD
Alfentanil—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000617	0.00323	CcSEcCtD
Alfentanil—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000611	0.0032	CcSEcCtD
Alfentanil—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000611	0.0032	CcSEcCtD
Alfentanil—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00061	0.0032	CcSEcCtD
Alfentanil—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000601	0.00315	CcSEcCtD
Alfentanil—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000599	0.00314	CcSEcCtD
Alfentanil—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000599	0.00314	CcSEcCtD
Alfentanil—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000598	0.00314	CcSEcCtD
Alfentanil—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000596	0.00313	CcSEcCtD
Alfentanil—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000596	0.00313	CcSEcCtD
Alfentanil—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000593	0.00311	CcSEcCtD
Alfentanil—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000593	0.00311	CcSEcCtD
Alfentanil—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000591	0.0031	CcSEcCtD
Alfentanil—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000587	0.00308	CcSEcCtD
Alfentanil—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000581	0.00305	CcSEcCtD
Alfentanil—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000579	0.00304	CcSEcCtD
Alfentanil—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000577	0.00302	CcSEcCtD
Alfentanil—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000571	0.00299	CcSEcCtD
Alfentanil—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000571	0.00299	CcSEcCtD
Alfentanil—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000568	0.00298	CcSEcCtD
Alfentanil—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000566	0.00297	CcSEcCtD
Alfentanil—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000563	0.00295	CcSEcCtD
Alfentanil—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00056	0.00294	CcSEcCtD
Alfentanil—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000558	0.00292	CcSEcCtD
Alfentanil—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000558	0.00292	CcSEcCtD
Alfentanil—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000543	0.00285	CcSEcCtD
Alfentanil—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000543	0.00285	CcSEcCtD
Alfentanil—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000539	0.00283	CcSEcCtD
Alfentanil—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000536	0.00281	CcSEcCtD
Alfentanil—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000532	0.00279	CcSEcCtD
Alfentanil—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000531	0.00278	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000527	0.00277	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000527	0.00277	CcSEcCtD
Alfentanil—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000527	0.00276	CcSEcCtD
Alfentanil—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000527	0.00276	CcSEcCtD
Alfentanil—Pain—Formoterol—chronic obstructive pulmonary disease	0.000522	0.00274	CcSEcCtD
Alfentanil—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000522	0.00274	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000517	0.00271	CcSEcCtD
Alfentanil—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000516	0.0027	CcSEcCtD
Alfentanil—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000513	0.00269	CcSEcCtD
Alfentanil—Pain—Montelukast—chronic obstructive pulmonary disease	0.000512	0.00268	CcSEcCtD
Alfentanil—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00051	0.00268	CcSEcCtD
Alfentanil—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000506	0.00265	CcSEcCtD
Alfentanil—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000506	0.00265	CcSEcCtD
Alfentanil—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000503	0.00264	CcSEcCtD
Alfentanil—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000503	0.00264	CcSEcCtD
Alfentanil—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000503	0.00264	CcSEcCtD
Alfentanil—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000501	0.00262	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000498	0.00261	CcSEcCtD
Alfentanil—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000497	0.00261	CcSEcCtD
Alfentanil—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000493	0.00259	CcSEcCtD
Alfentanil—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000485	0.00254	CcSEcCtD
Alfentanil—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000485	0.00254	CcSEcCtD
Alfentanil—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000483	0.00253	CcSEcCtD
Alfentanil—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000483	0.00253	CcSEcCtD
Alfentanil—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000481	0.00252	CcSEcCtD
Alfentanil—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000477	0.0025	CcSEcCtD
Alfentanil—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000477	0.0025	CcSEcCtD
Alfentanil—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000477	0.0025	CcSEcCtD
Alfentanil—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000475	0.00249	CcSEcCtD
Alfentanil—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000475	0.00249	CcSEcCtD
Alfentanil—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000474	0.00249	CcSEcCtD
Alfentanil—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000474	0.00249	CcSEcCtD
Alfentanil—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000473	0.00248	CcSEcCtD
Alfentanil—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000465	0.00244	CcSEcCtD
Alfentanil—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000458	0.0024	CcSEcCtD
Alfentanil—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000456	0.00239	CcSEcCtD
Alfentanil—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00045	0.00236	CcSEcCtD
Alfentanil—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00045	0.00236	CcSEcCtD
Alfentanil—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00045	0.00236	CcSEcCtD
Alfentanil—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000449	0.00235	CcSEcCtD
Alfentanil—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000441	0.00231	CcSEcCtD
Alfentanil—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000438	0.0023	CcSEcCtD
Alfentanil—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000438	0.0023	CcSEcCtD
Alfentanil—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000432	0.00227	CcSEcCtD
Alfentanil—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000432	0.00227	CcSEcCtD
Alfentanil—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000429	0.00225	CcSEcCtD
Alfentanil—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000425	0.00223	CcSEcCtD
Alfentanil—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000423	0.00222	CcSEcCtD
Alfentanil—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000416	0.00218	CcSEcCtD
Alfentanil—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000414	0.00217	CcSEcCtD
Alfentanil—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000408	0.00214	CcSEcCtD
Alfentanil—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000405	0.00213	CcSEcCtD
Alfentanil—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000404	0.00212	CcSEcCtD
Alfentanil—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000404	0.00212	CcSEcCtD
Alfentanil—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000396	0.00207	CcSEcCtD
Alfentanil—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000388	0.00204	CcSEcCtD
Alfentanil—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000388	0.00204	CcSEcCtD
Alfentanil—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000385	0.00202	CcSEcCtD
Alfentanil—Rash—Formoterol—chronic obstructive pulmonary disease	0.000385	0.00202	CcSEcCtD
Alfentanil—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000385	0.00202	CcSEcCtD
Alfentanil—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000385	0.00202	CcSEcCtD
Alfentanil—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000383	0.00201	CcSEcCtD
Alfentanil—Headache—Formoterol—chronic obstructive pulmonary disease	0.000383	0.00201	CcSEcCtD
Alfentanil—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000382	0.002	CcSEcCtD
Alfentanil—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000381	0.002	CcSEcCtD
Alfentanil—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000381	0.00199	CcSEcCtD
Alfentanil—Rash—Montelukast—chronic obstructive pulmonary disease	0.000377	0.00198	CcSEcCtD
Alfentanil—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000377	0.00198	CcSEcCtD
Alfentanil—Headache—Montelukast—chronic obstructive pulmonary disease	0.000375	0.00197	CcSEcCtD
Alfentanil—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000367	0.00192	CcSEcCtD
Alfentanil—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000364	0.00191	CcSEcCtD
Alfentanil—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000363	0.0019	CcSEcCtD
Alfentanil—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000363	0.0019	CcSEcCtD
Alfentanil—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000363	0.0019	CcSEcCtD
Alfentanil—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000361	0.00189	CcSEcCtD
Alfentanil—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000356	0.00187	CcSEcCtD
Alfentanil—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000355	0.00186	CcSEcCtD
Alfentanil—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000351	0.00184	CcSEcCtD
Alfentanil—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.00035	0.00183	CcSEcCtD
Alfentanil—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000345	0.00181	CcSEcCtD
Alfentanil—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000343	0.0018	CcSEcCtD
Alfentanil—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000333	0.00174	CcSEcCtD
Alfentanil—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000331	0.00173	CcSEcCtD
Alfentanil—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000323	0.00169	CcSEcCtD
Alfentanil—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.00032	0.00168	CcSEcCtD
Alfentanil—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000316	0.00166	CcSEcCtD
Alfentanil—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000307	0.00161	CcSEcCtD
Alfentanil—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000306	0.0016	CcSEcCtD
Alfentanil—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000302	0.00158	CcSEcCtD
Alfentanil—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000297	0.00155	CcSEcCtD
Alfentanil—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000295	0.00154	CcSEcCtD
Alfentanil—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000283	0.00148	CcSEcCtD
Alfentanil—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000278	0.00146	CcSEcCtD
Alfentanil—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000273	0.00143	CcSEcCtD
Alfentanil—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000271	0.00142	CcSEcCtD
Alfentanil—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000263	0.00138	CcSEcCtD
Alfentanil—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000259	0.00136	CcSEcCtD
Alfentanil—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000255	0.00134	CcSEcCtD
Alfentanil—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000254	0.00133	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000249	0.00131	CcSEcCtD
Alfentanil—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000244	0.00128	CcSEcCtD
Alfentanil—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.00024	0.00126	CcSEcCtD
Alfentanil—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000236	0.00124	CcSEcCtD
Alfentanil—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000235	0.00123	CcSEcCtD
Alfentanil—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000234	0.00122	CcSEcCtD
Alfentanil—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000232	0.00122	CcSEcCtD
Alfentanil—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000219	0.00115	CcSEcCtD
Alfentanil—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000209	0.00109	CcSEcCtD
Alfentanil—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000208	0.00109	CcSEcCtD
Alfentanil—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000207	0.00109	CcSEcCtD
Alfentanil—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000207	0.00109	CcSEcCtD
Alfentanil—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000198	0.00104	CcSEcCtD
Alfentanil—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000197	0.00103	CcSEcCtD
Alfentanil—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000191	0.001	CcSEcCtD
Alfentanil—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.00019	0.000996	CcSEcCtD
Alfentanil—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000177	0.000929	CcSEcCtD
Alfentanil—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000173	0.000904	CcSEcCtD
Alfentanil—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.00017	0.000892	CcSEcCtD
Alfentanil—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00016	0.0064	CbGpPWpGaD
Alfentanil—OPRM1—Peptide ligand-binding receptors—CXCR2—chronic obstructive pulmonary disease	0.00016	0.00639	CbGpPWpGaD
Alfentanil—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000159	0.000833	CcSEcCtD
Alfentanil—OPRM1—TCR Signaling Pathway—CD8A—chronic obstructive pulmonary disease	0.000159	0.00637	CbGpPWpGaD
Alfentanil—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000153	0.000801	CcSEcCtD
Alfentanil—ALB—Response to elevated platelet cytosolic Ca2+—SERPINA1—chronic obstructive pulmonary disease	0.000153	0.00613	CbGpPWpGaD
Alfentanil—Rash—Prednisone—chronic obstructive pulmonary disease	0.000152	0.000795	CcSEcCtD
Alfentanil—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000151	0.000794	CcSEcCtD
Alfentanil—Headache—Prednisone—chronic obstructive pulmonary disease	0.000151	0.00079	CcSEcCtD
Alfentanil—CYP3A7—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000147	0.00589	CbGpPWpGaD
Alfentanil—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000147	0.00588	CbGpPWpGaD
Alfentanil—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000146	0.00586	CbGpPWpGaD
Alfentanil—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000143	0.000749	CcSEcCtD
Alfentanil—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000141	0.00565	CbGpPWpGaD
Alfentanil—ALB—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.00014	0.00561	CbGpPWpGaD
Alfentanil—ALB—Platelet degranulation—TGFB2—chronic obstructive pulmonary disease	0.000139	0.00558	CbGpPWpGaD
Alfentanil—OPRM1—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	0.000135	0.00539	CbGpPWpGaD
Alfentanil—ABCB1—Allograft Rejection—IL13—chronic obstructive pulmonary disease	0.000134	0.00536	CbGpPWpGaD
Alfentanil—ALB—Response to elevated platelet cytosolic Ca2+—TGFB2—chronic obstructive pulmonary disease	0.000132	0.00531	CbGpPWpGaD
Alfentanil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000132	0.00529	CbGpPWpGaD
Alfentanil—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000131	0.00525	CbGpPWpGaD
Alfentanil—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000129	0.00518	CbGpPWpGaD
Alfentanil—CYP3A7—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000129	0.00518	CbGpPWpGaD
Alfentanil—CYP3A7—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000128	0.00512	CbGpPWpGaD
Alfentanil—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000125	0.00501	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—RAPGEF3—chronic obstructive pulmonary disease	0.000124	0.00497	CbGpPWpGaD
Alfentanil—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	0.000123	0.00493	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000122	0.00489	CbGpPWpGaD
Alfentanil—ALB—Vitamin B12 Metabolism—CRP—chronic obstructive pulmonary disease	0.000114	0.00457	CbGpPWpGaD
Alfentanil—CYP3A7—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000107	0.00431	CbGpPWpGaD
Alfentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000107	0.00429	CbGpPWpGaD
Alfentanil—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000106	0.00426	CbGpPWpGaD
Alfentanil—CYP3A7—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000106	0.00425	CbGpPWpGaD
Alfentanil—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	0.000104	0.00416	CbGpPWpGaD
Alfentanil—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000104	0.00416	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000102	0.0041	CbGpPWpGaD
Alfentanil—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	9.77e-05	0.00392	CbGpPWpGaD
Alfentanil—CYP3A5—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	9.34e-05	0.00374	CbGpPWpGaD
Alfentanil—ALB—Folate Metabolism—CRP—chronic obstructive pulmonary disease	9.27e-05	0.00372	CbGpPWpGaD
Alfentanil—CYP3A5—Biological oxidations—GCLC—chronic obstructive pulmonary disease	9.23e-05	0.0037	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	9.12e-05	0.00366	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	8.97e-05	0.0036	CbGpPWpGaD
Alfentanil—CYP3A7—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.96e-05	0.00359	CbGpPWpGaD
Alfentanil—OPRM1—Peptide ligand-binding receptors—EDN1—chronic obstructive pulmonary disease	8.94e-05	0.00358	CbGpPWpGaD
Alfentanil—CYP3A7—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	8.83e-05	0.00354	CbGpPWpGaD
Alfentanil—ALB—Vitamin B12 Metabolism—SERPINE1—chronic obstructive pulmonary disease	8.75e-05	0.00351	CbGpPWpGaD
Alfentanil—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	8.57e-05	0.00344	CbGpPWpGaD
Alfentanil—OPRM1—TCR Signaling Pathway—IL1B—chronic obstructive pulmonary disease	8.43e-05	0.00338	CbGpPWpGaD
Alfentanil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	8.38e-05	0.00336	CbGpPWpGaD
Alfentanil—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	8.37e-05	0.00335	CbGpPWpGaD
Alfentanil—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	8.27e-05	0.00332	CbGpPWpGaD
Alfentanil—CYP3A7—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	8.23e-05	0.0033	CbGpPWpGaD
Alfentanil—OPRM1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	8.15e-05	0.00327	CbGpPWpGaD
Alfentanil—CYP3A7—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	8.12e-05	0.00325	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	7.99e-05	0.0032	CbGpPWpGaD
Alfentanil—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	7.95e-05	0.00319	CbGpPWpGaD
Alfentanil—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	7.83e-05	0.00314	CbGpPWpGaD
Alfentanil—CYP3A7—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.8e-05	0.00313	CbGpPWpGaD
Alfentanil—CYP3A5—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.76e-05	0.00311	CbGpPWpGaD
Alfentanil—CYP3A7—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.7e-05	0.00309	CbGpPWpGaD
Alfentanil—CYP3A5—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.66e-05	0.00307	CbGpPWpGaD
Alfentanil—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	7.53e-05	0.00302	CbGpPWpGaD
Alfentanil—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	7.41e-05	0.00297	CbGpPWpGaD
Alfentanil—ALB—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	7.36e-05	0.00295	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	7.31e-05	0.00293	CbGpPWpGaD
Alfentanil—ALB—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	7.12e-05	0.00285	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	7.12e-05	0.00285	CbGpPWpGaD
Alfentanil—ALB—Vitamin B12 Metabolism—IL1B—chronic obstructive pulmonary disease	7.11e-05	0.00285	CbGpPWpGaD
Alfentanil—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	6.79e-05	0.00272	CbGpPWpGaD
Alfentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	6.71e-05	0.00269	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	6.67e-05	0.00268	CbGpPWpGaD
Alfentanil—OPRM1—TCR Signaling Pathway—TGFB1—chronic obstructive pulmonary disease	6.55e-05	0.00263	CbGpPWpGaD
Alfentanil—CYP3A5—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.48e-05	0.0026	CbGpPWpGaD
Alfentanil—CYP3A5—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.39e-05	0.00256	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	6.39e-05	0.00256	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—APIP—chronic obstructive pulmonary disease	6.28e-05	0.00252	CbGpPWpGaD
Alfentanil—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	6.24e-05	0.0025	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	6.17e-05	0.00247	CbGpPWpGaD
Alfentanil—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	6.12e-05	0.00245	CbGpPWpGaD
Alfentanil—ALB—Platelet degranulation—SERPINE1—chronic obstructive pulmonary disease	6.1e-05	0.00245	CbGpPWpGaD
Alfentanil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	6.09e-05	0.00244	CbGpPWpGaD
Alfentanil—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	6.01e-05	0.00241	CbGpPWpGaD
Alfentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	6e-05	0.0024	CbGpPWpGaD
Alfentanil—CYP3A5—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.95e-05	0.00239	CbGpPWpGaD
Alfentanil—CYP3A5—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.87e-05	0.00235	CbGpPWpGaD
Alfentanil—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—chronic obstructive pulmonary disease	5.81e-05	0.00233	CbGpPWpGaD
Alfentanil—ALB—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	5.78e-05	0.00232	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	5.71e-05	0.00229	CbGpPWpGaD
Alfentanil—ALB—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	5.66e-05	0.00227	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5.66e-05	0.00227	CbGpPWpGaD
Alfentanil—CYP3A5—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.64e-05	0.00226	CbGpPWpGaD
Alfentanil—CYP3A5—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.56e-05	0.00223	CbGpPWpGaD
Alfentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	5.25e-05	0.0021	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	5.19e-05	0.00208	CbGpPWpGaD
Alfentanil—ALB—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	5.16e-05	0.00207	CbGpPWpGaD
Alfentanil—OPRM1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	5.11e-05	0.00205	CbGpPWpGaD
Alfentanil—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	4.94e-05	0.00198	CbGpPWpGaD
Alfentanil—OPRM1—TCR Signaling Pathway—IL6—chronic obstructive pulmonary disease	4.94e-05	0.00198	CbGpPWpGaD
Alfentanil—OPRM1—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	4.83e-05	0.00194	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	4.6e-05	0.00185	CbGpPWpGaD
Alfentanil—ALB—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	4.59e-05	0.00184	CbGpPWpGaD
Alfentanil—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	4.57e-05	0.00183	CbGpPWpGaD
Alfentanil—OPRM1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	4.57e-05	0.00183	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	4.54e-05	0.00182	CbGpPWpGaD
Alfentanil—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	4.39e-05	0.00176	CbGpPWpGaD
Alfentanil—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.34e-05	0.00174	CbGpPWpGaD
Alfentanil—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.29e-05	0.00172	CbGpPWpGaD
Alfentanil—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	4.29e-05	0.00172	CbGpPWpGaD
Alfentanil—ALB—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	4.2e-05	0.00168	CbGpPWpGaD
Alfentanil—ALB—Folate Metabolism—TNF—chronic obstructive pulmonary disease	4.2e-05	0.00168	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	4.18e-05	0.00168	CbGpPWpGaD
Alfentanil—ALB—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	4.16e-05	0.00167	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.16e-05	0.00167	CbGpPWpGaD
Alfentanil—OPRM1—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	4.08e-05	0.00163	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—GC—chronic obstructive pulmonary disease	4.05e-05	0.00162	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	4.04e-05	0.00162	CbGpPWpGaD
Alfentanil—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	4e-05	0.0016	CbGpPWpGaD
Alfentanil—OPRM1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	4e-05	0.0016	CbGpPWpGaD
Alfentanil—ALB—Metabolism—APIP—chronic obstructive pulmonary disease	3.91e-05	0.00157	CbGpPWpGaD
Alfentanil—ALB—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	3.85e-05	0.00154	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.76e-05	0.00151	CbGpPWpGaD
Alfentanil—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	3.72e-05	0.00149	CbGpPWpGaD
Alfentanil—ALB—Folate Metabolism—TP53—chronic obstructive pulmonary disease	3.7e-05	0.00148	CbGpPWpGaD
Alfentanil—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	3.67e-05	0.00147	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	3.67e-05	0.00147	CbGpPWpGaD
Alfentanil—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.61e-05	0.00145	CbGpPWpGaD
Alfentanil—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.56e-05	0.00143	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	3.42e-05	0.00137	CbGpPWpGaD
Alfentanil—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	3.41e-05	0.00137	CbGpPWpGaD
Alfentanil—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	3.39e-05	0.00136	CbGpPWpGaD
Alfentanil—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	3.33e-05	0.00134	CbGpPWpGaD
Alfentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	3.24e-05	0.0013	CbGpPWpGaD
Alfentanil—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	3.18e-05	0.00128	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	3.18e-05	0.00127	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.06e-05	0.00123	CbGpPWpGaD
Alfentanil—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.01e-05	0.00121	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.01e-05	0.00121	CbGpPWpGaD
Alfentanil—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.97e-05	0.00119	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	2.92e-05	0.00117	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.89e-05	0.00116	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	2.85e-05	0.00114	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.79e-05	0.00112	CbGpPWpGaD
Alfentanil—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.77e-05	0.00111	CbGpPWpGaD
Alfentanil—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.73e-05	0.00109	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.72e-05	0.00109	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	2.71e-05	0.00109	CbGpPWpGaD
Alfentanil—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	2.69e-05	0.00108	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.62e-05	0.00105	CbGpPWpGaD
Alfentanil—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.62e-05	0.00105	CbGpPWpGaD
Alfentanil—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.59e-05	0.00104	CbGpPWpGaD
Alfentanil—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.59e-05	0.00104	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.58e-05	0.00103	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	2.57e-05	0.00103	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.57e-05	0.00103	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GC—chronic obstructive pulmonary disease	2.52e-05	0.00101	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.47e-05	0.00099	CbGpPWpGaD
Alfentanil—OPRM1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.47e-05	0.00099	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.34e-05	0.00094	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.34e-05	0.000939	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.27e-05	0.000909	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.26e-05	0.000905	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.21e-05	0.000886	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	2.21e-05	0.000885	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	2.18e-05	0.000876	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.11e-05	0.000846	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.05e-05	0.000822	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.05e-05	0.000822	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.01e-05	0.000805	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	1.99e-05	0.000799	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.87e-05	0.000748	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	1.86e-05	0.000746	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	1.84e-05	0.000737	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.84e-05	0.000736	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.83e-05	0.000735	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.81e-05	0.000724	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	1.8e-05	0.000723	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.76e-05	0.000705	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	1.71e-05	0.000685	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.68e-05	0.000675	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.68e-05	0.000673	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	1.66e-05	0.000664	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.65e-05	0.000661	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.6e-05	0.00064	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	1.58e-05	0.000633	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.57e-05	0.00063	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.55e-05	0.000621	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.53e-05	0.000614	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.51e-05	0.000606	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	1.44e-05	0.000578	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.41e-05	0.000564	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.4e-05	0.00056	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	1.4e-05	0.000559	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.39e-05	0.000559	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.39e-05	0.000555	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.38e-05	0.000555	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.38e-05	0.000552	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	1.36e-05	0.000545	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.36e-05	0.000545	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.33e-05	0.000535	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	1.33e-05	0.000534	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.33e-05	0.000532	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.27e-05	0.000508	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.26e-05	0.000507	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.26e-05	0.000504	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	1.24e-05	0.000497	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.21e-05	0.000486	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.21e-05	0.000483	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.19e-05	0.000478	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.14e-05	0.000458	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.13e-05	0.000451	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.11e-05	0.000444	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.09e-05	0.000438	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.09e-05	0.000436	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.06e-05	0.000423	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.02e-05	0.000408	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1e-05	0.000402	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.65e-06	0.000387	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	9.6e-06	0.000385	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.54e-06	0.000382	CbGpPWpGaD
Alfentanil—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.41e-06	0.000377	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.26e-06	0.000371	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	9.07e-06	0.000364	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.84e-06	0.000354	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	8.81e-06	0.000353	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.76e-06	0.000351	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	8.68e-06	0.000348	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.44e-06	0.000338	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.36e-06	0.000335	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.31e-06	0.000333	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.24e-06	0.00033	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.68e-06	0.000308	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.48e-06	0.0003	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.43e-06	0.000298	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	7.34e-06	0.000294	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.28e-06	0.000292	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	7.25e-06	0.000291	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.12e-06	0.000285	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.77e-06	0.000271	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	6.7e-06	0.000269	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	6.56e-06	0.000263	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	6.27e-06	0.000251	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.17e-06	0.000247	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.08e-06	0.000244	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.58e-06	0.000224	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.47e-06	0.000219	CbGpPWpGaD
Alfentanil—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	5.4e-06	0.000217	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.15e-06	0.000206	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.08e-06	0.000204	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	4.95e-06	0.000198	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.73e-06	0.00019	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.73e-06	0.00019	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.59e-06	0.000184	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.48e-06	0.00018	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.2e-06	0.000169	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.05e-06	0.000122	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.92e-06	0.000117	CbGpPWpGaD
